Hillstream BioPharma Inc.

NASDAQ: HILS · Real-Time Price · USD
0.24
0.02 (7.00%)
At close: Sep 22, 2023, 9:59 PM

Hillstream BioPharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a
Cost of Revenue
n/a n/a n/a
Gross Profit
n/a n/a n/a
Operating Income
-9.46M -6.88M -3.21M
Interest Income
152.63K n/a n/a
Pretax Income
-9.32M -8.47M -2.21M
Net Income
-9.32M -8.47M -3.04M
Selling & General & Admin
5.9M 4.6M 1.37M
Research & Development
3.56M 2.28M 1.84M
Other Expenses
n/a n/a 1.83M
Operating Expenses
9.46M 6.88M 3.21M
Interest Expense
-16.5K 1.59M 831.28K
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
9.46M 6.88M 3.21M
Income Tax Expense
n/a n/a 831.28K
Shares Outstanding (Basic)
1.31M 11.23M 10.3M
Shares Outstanding (Diluted)
1.31M 11.23M 10.3M
EPS (Basic)
-7.14 -0.75 -0.3
EPS (Diluted)
-7.14 -0.75 -0.3
EBITDA
-9.46M -6.88M -1.38M
EBIT
-9.34M n/a -1.38M
Depreciation & Amortization
167.9K 1.57B 1.83M